Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

EMD Serono Research & Development Institute, Inc. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
head-and-neck-cancer
head and neck cancer, adjuvant radiotherapy (rt), stage iii, stage iva, stage ivb, oral cavity, oropharynx, larynx, hypopharynx, unfit, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861036
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.